2m 2m 2m 2m 2m 2m 2m
Mckesson (MCK)
NYSE
$763.62+$18.77 (+2.52%)
Price as of Jun 23, 2026 2:45 PM EDT- $87.2BMarket Cap
- 3.61%1-Year Change
- Medical DistributionIndustry
Mckesson (MCK)
$763.62+$18.77 (+2.52%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 403.4B +12.36% | 359.1B +16.22% | 309.0B +11.65% | 276.7B +4.83% | |
Cost of Revenue | 388.9B +12.48% | 345.7B +16.75% | 296.1B +12.02% | 264.4B +5.39% | |
Gross Profit | 14.6B +9.21% | 13.3B +3.86% | 12.8B +3.80% | 12.4B -5.88% | |
Sales and Marketing Expense | 8.1B -4.83% | 8.5B -1.73% | 8.7B +11.33% | 7.8B -26.20% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 256.0M +5.79% | 242.0M -4.35% | 253.0M +2.02% | 248.0M -11.11% | |
Total Operating Expenses | 8.3B -6.33% | 8.9B -0.20% | 8.9B +11.81% | 8.0B -28.08% | |
Operating Profit | 6.2B +40.48% | 4.4B +13.12% | 3.9B -10.77% | 4.4B +114.97% | |
Interest Income | 179.0M +3.47% | 173.0M +46.61% | 118.0M +10.28% | 107.0M +970.00% | |
Interest Expense | N/A N/A | N/A N/A | -252.0M +1.61% | -248.0M +39.33% | |
Interest Income and Expense and Net | 179.0M +3.47% | 173.0M +229.10% | -134.0M -4.96% | -141.0M -16.07% | |
Total Nonoperating Income and Expense | 236.0M +16.83% | 202.0M +53.03% | 132.0M -73.44% | 497.0M +91.89% | |
Income before Taxes | 6.2B +42.26% | 4.4B +15.04% | 3.8B -18.16% | 4.6B +140.15% | |
Income Taxes | 1.1B +25.51% | 878.0M +39.59% | 629.0M -30.50% | 905.0M +42.30% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Net Income | 4.8B +44.52% | 3.3B +9.76% | 3.0B -15.67% | 3.6B +219.57% | |
Net Income from Continuing Operations Applicable to Common | 4.8B +9.25% | 4.4B +15.04% | 3.8B -18.16% | 4.6B +140.15% | |
Basic EPS and Net Income | 38.55 +49.07% | 25.86 +14.73% | 22.54 -10.66% | 25.23 +244.67% | |
Diluted EPS and Net Income | 38.38 +49.22% | 25.72 +14.87% | 22.39 -10.55% | 25.03 +246.20% | |
Basic Weighted Average Shares | 123.6M -2.98% | 127.4M -4.35% | 133.2M -5.60% | 141.1M -7.35% | |
Diluted Weighted Average Shares | 124.1M -3.12% | 128.1M -4.47% | 134.1M -5.70% | 142.2M -7.72% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.0B -30.15% | 5.7B +24.18% | 4.6B -2.03% | 4.7B +32.45% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.0B -30.15% | 5.7B +24.18% | 4.6B -2.03% | 4.7B +32.45% | |
Total Current Assets | 57.2B +3.27% | 55.4B +15.48% | 48.0B +8.30% | 44.3B -4.19% | |
Accumulated Depreciation | 2.6B +3.36% | 2.5B +2.51% | 2.5B +10.58% | 2.2B +11.89% | |
Property and Plant and Equipment and Net | 2.7B +6.63% | 2.5B +8.03% | 2.3B +6.38% | 2.2B +4.06% | |
Total Long-Term Assets | 5.0B +25.68% | 4.0B +24.67% | 3.2B +59.94% | 2.0B +3.91% | |
Total Assets | 82.3B +9.56% | 75.1B +11.41% | 67.4B +8.22% | 62.3B -1.55% | |
Income Taxes Payable | 1.3B +29.25% | 1.0B +12.21% | 917.0M -33.89% | 1.4B -2.19% | |
Total Short-Term Debt | 1.3B +6.38% | 1.2B +2,282.00% | 50.0M -94.83% | 968.0M +21.15% | |
Total Current Liabilities | 67.0B +8.79% | 61.6B +17.66% | 52.4B +9.17% | 48.0B -1.05% | |
Total Long-Term Debt | 5.3B +17.84% | 4.5B -20.00% | 5.6B +20.60% | 4.6B -8.94% | |
Total Long-Term Liabilities | 2.7B 0.00% | 2.7B +1.88% | 2.6B +43.96% | 1.8B +17.73% | |
Total Liabilities | 68.8B +9.09% | 63.1B +17.20% | 53.8B +9.04% | 49.4B -0.95% | |
Retained Earnings | 22.3B +24.38% | 17.9B +19.65% | 15.0B +21.82% | 12.3B +36.16% | |
Total Stockholders Equity | -2.2B +4.73% | -2.1B +5.23% | -2.0B +6.14% | -1.9B -18.27% | |
Total Shares Outstanding | 280.0M +0.36% | 279.0M +0.36% | 278.0M +0.36% | 277.0M +0.73% | |
Cash Flow | |||||
Cash from Operating Activities | 6.2B +1.15% | 6.1B +41.05% | 4.3B -16.38% | 5.2B +16.35% | |
Capital Expenditures | 436.0M -18.81% | 537.0M +24.59% | 431.0M +10.51% | 390.0M +0.52% | |
Cash from Investing Activities | -3.4B +368.21% | -733.0M -31.62% | -1.1B +97.79% | -542.0M +508.99% | |
Dividends Paid | 381.0M +10.43% | 345.0M +9.87% | 314.0M +7.53% | 292.0M +5.42% | |
Cash from Financing Activities | -4.6B +16.80% | -4.0B +18.64% | -3.3B -23.49% | -4.4B -30.90% | |
Financials Ratio | |||||
Gross Margin | 3.61% -2.80% | 3.71% -10.63% | 4.15% -7.03% | 4.47% -10.21% | |
Operating Margin | 1.54% +25.02% | 1.23% -2.66% | 1.27% -20.09% | 1.58% +105.05% | |
Return on Assets | 6.05% +30.86% | 4.62% -0.11% | 4.63% -18.37% | 5.67% +226.42% | |
Return on Equity | -224.31% +37.68% | -162.92% +3.87% | -156.84% -9.04% | -172.44% +77.47% | |
Revenue Growth | 12.36% -23.78% | 16.22% +39.18% | 11.65% +141.31% | 4.83% -55.31% | |
Current Ratio | 0.85 -5.07% | 0.90 -1.84% | 0.92 -0.80% | 0.92 -3.18% | |
Cash Ratio | 0.06 -35.82% | 0.09 +5.60% | 0.09 -10.26% | 0.10 +33.74% | |
Debt-to-Equity Ratio | -3.00 +10.22% | -2.73 -4.54% | -2.86 -5.20% | -3.01 +16.42% | |
Debt-to-Assets Ratio | 0.08 +5.45% | 0.08 -9.94% | 0.08 -7.02% | 0.09 -3.34% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow